PT - JOURNAL ARTICLE AU - Samuel W. Cramer AU - Laurentiu S. Popa AU - Russell E. Carter AU - Gang Chen AU - Timothy J. Ebner TI - Abnormal Excitability and Episodic Low-Frequency Oscillations in the Cerebral Cortex of the <em>tottering</em> Mouse AID - 10.1523/JNEUROSCI.3107-14.2015 DP - 2015 Apr 08 TA - The Journal of Neuroscience PG - 5664--5679 VI - 35 IP - 14 4099 - http://www.jneurosci.org/content/35/14/5664.short 4100 - http://www.jneurosci.org/content/35/14/5664.full SO - J. Neurosci.2015 Apr 08; 35 AB - The Ca2+ channelopathies caused by mutations of the CACNA1A gene that encodes the pore-forming subunit of the human Cav2.1 (P/Q-type) voltage-gated Ca2+ channel include episodic ataxia type 2 (EA2). Although, in EA2 the emphasis has been on cerebellar dysfunction, patients also exhibit episodic, nonmotoric abnormalities involving the cerebral cortex. This study demonstrates episodic, low-frequency oscillations (LFOs) throughout the cerebral cortex of tottering (tg/tg) mice, a widely used model of EA2. Ranging between 0.035 and 0.11 Hz, the LFOs in tg/tg mice can spontaneously develop very high power, referred to as a high-power state. The LFOs in tg/tg mice are mediated in part by neuronal activity as tetrodotoxin decreases the oscillations and cortical neuron discharge contain the same low frequencies. The high-power state involves compensatory mechanisms because acutely decreasing P/Q-type Ca2+ channel function in either wild-type (WT) or tg/tg mice does not induce the high-power state. In contrast, blocking l-type Ca2+ channels, known to be upregulated in tg/tg mice, reduces the high-power state. Intriguingly, basal excitatory glutamatergic neurotransmission constrains the high-power state because blocking ionotropic or metabotropic glutamate receptors results in high-power LFOs in tg/tg but not WT mice. The high-power LFOs are decreased markedly by acetazolamide and 4-aminopyridine, the primary treatments for EA2, suggesting disease relevance. Together, these results demonstrate that the high-power LFOs in the tg/tg cerebral cortex represent a highly abnormal excitability state that may underlie noncerebellar symptoms that characterize CACNA1A mutations.